ELI LILLY & Co — SEC insider filings
SEC reporting owner CIK 59478. 6 insider filings on record with FilingPulse; latest filed 2026-10-22.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2020-12-10 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings — 66,295,950 shares, $1,177,356,018 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 34,284,789 shares @ $22.50 ($771,407,752) in Prevail Therapeutics Inc., filed 2021-01-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Prevail Therapeutics Inc. (PRVL) | 10% owner | 1 | 1 leg · 34,284,789 sh · $771,407,752 | — | — |
| Akouos, Inc. (AKUS) | 10% owner | 1 | 1 leg · 29,992,668 sh · $374,908,350 | — | — |
| Sigilon Therapeutics, Inc. (SGTX) | 10% owner | 2 | 2 legs · 2,018,493 sh · $31,039,916 | — | 3 |
| Lycia Therapeutics, Inc. (LYCA) | 10% owner | 1 | — | — | — |
| TRex Bio, Inc. (TRXB) | 10% owner | 1 | — | — | — |
Insider filings — ELI LILLY & Co
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-22 | 3 | Lycia Therapeutics, Inc. (LYCA) | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 3 | TRex Bio, Inc. (TRXB) | Holdings only — no transactions reported | EDGAR |
| 2023-08-14 | 4 | Sigilon Therapeutics, Inc. (SGTX) jointly with Shenandoah Acquisition Corp | Purchase (P): 1,718,493 @ $14.92 | EDGAR |
| 2022-12-01 | 4 | Akouos, Inc. (AKUS) jointly with Kearny Acquisition Corp | Purchase (P): 29,992,668 @ $12.50 | EDGAR |
| 2021-01-22 | 4 | Prevail Therapeutics Inc. (PRVL) jointly with Tyto Acquisition Corp | Purchase (P): 34,284,789 @ $22.50 | EDGAR |
| 2020-12-10 | 4 | Sigilon Therapeutics, Inc. (SGTX) | Conversion (C): 2,444,443 · Purchase (P): 300,000 @ $18 · Conversion (C): 1,555,555 (derivative) · Conversion (C): 888,888 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=59478 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs